FAQs

The Global NGO Deworming Inventory collates district-level data on NGO deworming activities that treat soil-transmitted helminthiasis (STH), schistosomiasis, and/or lymphatic filariasis (LF).

The Inventory will serve as a reliable repository of NGO deworming treatment data accessible to and for use by the deworming community.

http://www.deworminginventory.org/faqs/what-is-the-inventory-of-ngo-deworming-programs

The 2001 World Health Assembly resolution (WHA54.19) set a target for member nations to treat at least 75 percent of all school-aged children at risk of illness from STH and Schistosomiasis by 2010.

The WHO’s Preventive Chemotherapy (PCT) databank, which was set up to measure progress towards this goal, currently estimates that only 11 percent of at-risk school-age children have been treated with an anthelminthic drug. It is believed that this figure is an underestimation of the true scale of treatment coverage as it does not reflect treatment data of NGOs.

Improved information on who is deworming and where and how many children are being dewormed can facilitate sharing of best practices, strengthen collaborative and strategic partnerships, and promote coordinated advocacy, robust program monitoring, and efficient use of resources.

http://www.deworminginventory.org/faqs/why-is-the-inventory-needed

The objectives of the Inventory are to:

• Identify who is deworming where and how many people are being dewormed.
• Provide a better estimate on the scope and extent of NGO deworming activities and associated treatment data.
• Provide a platform for information sharing amongst deworming programs.
• Disseminate data on deworming programs that provide any of the following drugs: albendazole, mebendazole, praziquantel, or ivermectin to treat or prevent soil-transmitted helminthiasis (STH), schistosomiasis, and lymphatic filariasis (LF).

http://www.deworminginventory.org/faqs/what-are-the-objectives-of-the-inventory

The Inventory will complement the WHO PCT databank, which includes deworming treatment data from Ministries of Health, by providing deworming treatment data from NGOs.

Information provided for the Inventory will be shared with the WHO PCT databank for generation of complete national level treatment reports (see below for further details on how information will be used).

http://www.deworminginventory.org/faqs/how-is-the-inventory-related-to-the-who-pct-databank

By participating in this Inventory, you can:

• Have your deworming accomplishments counted as part of the global efforts to fight parasitic worms.
• See how your deworming activities contribute to the global target of treating 75 percent of at-risk school-age children.
• Identify areas/populations not currently covered to inform program expansion.
• Share your knowledge and experience and learn from the experience of other deworming programs
• Identify organizations deworming in the same area and form mutually beneficial partnerships that enhance your activities.
• Be an integral part of the parasitic worm control community and advocate for increased resources for deworming.

http://www.deworminginventory.org/faqs/why-should-my-organization-participate-in-the-inventory

There are two ways to participate in the Inventory.

• Option 1: Download, complete, and submit the 2011 Treatment Reporting Form. Use the 2011 Treatment Reporting Guide to assist in completing the form. Send completed form to info@deworminginventory.org.

• Option 2: You can submit a copy of your latest report of your deworming accomplishments to info@deworminginventory.org. If you choose this option, please be sure that your report includes all the required data elements as described in the 2011 Treatment Reporting Guide.

http://www.deworminginventory.org/faqs/how-do-i-participate-in-the-inventory

Data elements to be collected include:

Organizational Information

• Organization name
• Organization contact information

Deworming Program Information

• Countries/districts you deworm in
• Diseases targeted
• Drug(s) provided (albendazole; mebendazole; other)
• Source of drug(s)
• Number of people treated for each disease per district at last treatment round (segmented by target population)

Definitions for these data elements are included in the 2011 Treatment Reporting Guide.

http://www.deworminginventory.org/faqs/what-type-of-data-will-i-be-expected-to-provide

The following bullet points describe how the data you provide will be used:

• No one organization, including Children Without Worms (CWW), the Schistosomiasis Control Initiative (SCI), or Deworm the World (DtW), will own the Inventory and the data contained therein.
• The Data Use and Sharing Policy will guide the use of information gathered for the Inventory.
• Aggregate level data will be produced from information collected and made available on the "Reports" page of this web site.
• Data submitted will be shared with the WHO, subject to the terms of the Data Use and Sharing Policy.
• Data submitted will also be shared with respective Ministries of Health and Education.
• Aggregate level data will be analyzed to identify geographic gaps in treatment coverage.
• CWW, SCI, and DtW will not own the data.
• CWW, SCI, and DtW will not use the data other than for the purposes described above.

http://www.deworminginventory.org/faqs/how-will-the-information-i-provide-be-used

Due to its collaboration with other NTD programs and its extensive network of partners, Children Without Worms was asked to coordinate the planning and implementation of the Inventory by the WHO Working Group on Access to Assured-Quality Essential Medicines for Neglected Tropical Diseases (WGA). See the WGA mandate to CWW.

• CWW is a partnership between Johnson & Johnson and The Task Force for Global Health. CWW provides mebendazole to treat children in eight countries and partners with governments and organizations to stop reinfection through hygiene education and access to improved sanitation and clean water. To learn more about CWW, please visit www.childrenwithoutworms.org.
• CWW’s relationship and proximity to other large NTD control programs housed at the Task Force such as the Lymphatic Filariasis Support Center (LFSC), the Mectizan Donation Program (MDP), and the International Trachoma Initiative (ITI), position it to draw on lessons learned from these other global initiatives.

CWW has partnered with the Schistosomiasis Control Initiative (SCI) and Deworm the World (DtW) to increase awareness of the Inventory and thereby ensure its success.

http://www.deworminginventory.org/faqs/who-is-implementing-this-project

CWW has two essential roles in the Inventory:

• Identifying deworming programs through a web search and through its partners.
• Coordinating the collection of treatment data and producing reports to facilitate sharing of information.

http://www.deworminginventory.org/faqs/what-is-the-role-of-cww